Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.040 | 1.100 | 0.0600 |
| Révision: | $258.05M | $267.70M | $9.22M |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.100 | 1.070 | -0.0300 |
| Révision: | $264.66M | $272.49M | -$2.31M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.120 | 1.160 | 0.0400 |
| Révision: | $273.49M | $278.31M | -$2.56M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.130 | 0.910 | -0.2200 |
| Révision: | $257.95M | $275.21M | $18.94M |
